Initially, an EdU assay was conducted, which indicated that cell growth, assessed as the percentage of EdU-positive cells, was significantly inhibited in IFI6-silenced ESCC cells compared with ShControl ESCC cells (Fig. 3a, b). Here, IFI6 is linked to esophageal squamous cell carcinoma.